Zylox-Tonbridge to acquire German medical technology company Optimed
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology…
Zylox-Tonbridge, a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology…
Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting improved progression-free survival…
Novartis has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ianalumab, a treatment…
BD (Becton, Dickinson and Company) has received 510(k) approval from the US Food and Drug Administration (FDA) for the EnCor…
Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 (esreboxetine) for the management of fibromyalgia, with the first…
Agenus has completed a $141m strategic collaboration with Zydus Lifesciences to accelerate the global development and potential commercialisation of its…
US-based virtual care solution provider CareView has announced a new virtual care partnership in healthcare with national sales organisation MedPro.…
PointClickCare has announced the forthcoming launch of Referral Advisor, its latest AI-powered solution aimed at improving referral management for skilled…
Baxter International unveiled the Dynamo Series smart stretcher to reduce the care team’s workload and enhance patient care by addressing…
Tampa General Hospital (TGH) and Boston-based Mass General Brigham (MGB) have launched a joint ambulatory care network on Florida’s East…